Company registration number: 2977135 Charity registration number: 1049067
## Wythenshawe Hospital Transplant Fund
(A company limited by guarantee)
Annual Report and Financial Statements
for the Year Ended 31 March 2022
## **Wythenshawe Hospital Transplant Fund**
## **Contents**
|Reference and Administrative Details|1|
|---|---|
|Trustees' Report|2 to 4|
|Statement of Trustees' Responsibilities|5|
|Independent Examiner's Report|6|
|Statement of Financial Activities|7 to 8|
|Balance Sheet|9|
|Notes to the Financial Statements|10 to 19|
|**Wythenshawe Hospital Transplant Fund**|**Wythenshawe Hospital Transplant Fund**|
|---|---|
||**Reference and Administrative Details**|
|**Trustees**|Dr M Al-aloul|
||Dr P Callan|
||D K Cornwall|
||N Eadie|
||S Fowler|
||E Mather|
||W Noble|
||R Venkateswaran|
|**Secretary**|L C Ellis|
|**Principal Office**|The Transplant Fund Office|
||Transplant Centre|
||Wythenshawe Hospital|
||Manchester|
||M23 9LT|
||The charity is incorporated in England and Wales.|
|**Company Registration Number**|2977135|
|**Charity Registration Number**|1049067|
|**Solicitors**|Addleshaw Goddard|
||One St Peter's Square|
||Manchester|
||M2 3DE|
|**Bankers**|HSBC Bank plc|
||11 Stamford New Road|
||Altrincham|
||WA14 1BW|
||W H Ireland|
||11 St James's Square|
||Manchester|
||M2 6WH|
|**Independent Examiner**|Maria Hallows BA (Econs), FCA, DCha|
||Chartered Accountant|
||Beever and Struthers|
||One Express|
||1 George Leigh Street|
||Manchester|
||M5 4DL|
Page 1
## **Wythenshawe Hospital Transplant Fund**
## **Trustees' Report**
The trustees, who are directors for the purposes of company law, present the annual report together with the financial statements of the charitable company for the year ended 31 March 2022.
## **Trustees**
Dr M Al-aloul Dr P Callan (appointed 22 June 2022)
D K Cornwall
R G Dyson, Chair (resigned 1 December 2021)
N Eadie
S Fowler
M M Harrison (resigned 7 December 2022)
E Mather
W Noble B E Quick (resigned 1 December 2021) R Venkateswaran
## **Objectives and activities**
## _**Objects and aims**_
In setting our objectives and planning our activities, the Trustees have given careful consideration to the Charity Commission’s general guidance on public benefit.
As determined by the charity's Memorandum and Articles of Association, the principal activity of the charity is to support the programme of heart and lung transplantation at Wythenshawe Hospital, Manchester, serving the North West of England. Whilst the NHS provides substantial funds for the transplant centre there is always a demand for state-of-the-art equipment or money to support pioneering treatments and research which the NHS is unwilling to fund. The charity plays a vital role by providing funds to accelerate the adoption of new procedures and by funding research which advances the technology surrounding transplantation, thus enabling the Wythenshawe Transplant Centre to remain at the forefront of excellence for the treatment of cardiac and lung disease.
The charity is in regular contact with Wythenshawe Hospital and receives funding requests from the hospital. The Board determines whether to meet these requests for funding. The charity does not enter into contractual relationships with suppliers of equipment and services. It only provides the agreed funding. The Trustees’ policy is to approve all major grants prior to commitment of funds. With the exception of minor funding of up to £5,000, which may be approved by the Chairman, decisions relating to the allocation of funds are reserved to the Board and cannot be delegated.
## _**Public benefit**_
All the activities of the charity are undertaken to further public benefit.
The trustees confirm that they have complied with the requirements of section 17 of the Charities Act 2011 to have due regard to the public benefit guidance published by the Charity Commission for England and Wales.
Page 2
## **Wythenshawe Hospital Transplant Fund**
## **Trustees' Report**
## **Achievements and performance**
Voluntary donations, legacies and other trading activities raised a total of £198,166 (2021: £550,430), grant income of £5,000 (2021: Nil) and investment income on our investments and cash deposits generated £16,834 (2021: £8,170). This allowed the Trustees to continue the charity's support for most of the requests submitted to the charity. During the year the charity has contributed Nil (2021: £480,260) to the refurbishment of the ground floor of the Transplant Centre as this had finished in the previous financial year, contributed Nil (2021: £100,000) towards the cost of a new scanner and donated £45,375 (2021: £71,807) to fund the purchase of a number of items of equipment for use in the Transplant Centre and to contribute to the costs of recipients who participate in the Transplant Games.
## **Financial review**
The results for the year and their impact on the charity's funds are set out in detail in the statement of financial activities. Total net income for the year was £155,495 (2021: net expenditure £84,685) and the year end net assets amounted to £1,341,198 (2021: £1,185,703), including £1,202,726 (2021: £860,237) in cash at the bank or invested in UK Government Stocks, corporate bond funds and Open Ended Investment Companies.
## _**Policy on reserves**_
The charity's reserves are represented by its investments and cash balances. The Trustees have reviewed the charity’s requirements for unrestricted reserves in the light of the main risks to the organisation. In the opinion of the Trustees, sufficient unrestricted reserves are required to meet one year’s operating costs in the event of a significant drop in incoming resources and £50,000 is considered to be adequate for this purpose. The balance of the unrestricted reserves is available to be used to fund projects in accordance with the charity's objects.
## _**Investment policy and objectives**_
The Trustees are empowered to invest and deal with the monies of the charity not immediately required in such a manner as the charity may from time to time determine subject to such conditions and consents imposed or required by law. Surplus funds are placed on deposit either with the charity's bankers or with W H Ireland Ltd or invested in UK Government Stocks, corporate bond funds and unit trusts. Investment returns are governed by the prevailing interest rates and dividend payments.
## **Structure, governance and management**
## _**Recruitment and appointment of trustees**_
No person may be appointed as a Trustee unless approved by all the Trustees. At every general meeting one third of the Trustees retire by rotation being decided by the length of time in office. Subject to the above, University Hospital of South Manchester NHS Foundation Trust (now Manchester University NHS Foundation Trust) may appoint one Trustee. Trustees must be aged 18 years or above and not disqualified by reason of Article 10.1 of the charity's Articles of Association or in company or charity law. None of the Trustees have any interest in the charity. Trustees are appointed under the provision of Articles 31 to 33 of the charity's Articles of Association.
## _**Induction and training of trustees**_
All new Trustees receive a formal briefing from the Chairman of their duties and responsibilities and receive various booklets from the Charity Commission and Companies House. Trustees are also encouraged to keep themselves abreast of current and proposed developments in charity regulation through access to the Charity Commission website and other relevant sources of information.
Page 3
## **Wythenshawe Hospital Transplant Fund**
## **Trustees' Report**
## _**Major risks and management of those risks**_
The Trustees continue to review the charity's activities to identify the major risks to which it is exposed and the systems established to mitigate risks are periodically reviewed to ensure that they are operating effectively and still meet the needs of the charity. It has been determined that the principal risks and uncertainties are the volatility of investments held by the charity and the continued ability to raise voluntary income. The steps taken by the Trustees to mitigate these risks as far as practicable are to maintain and regularly review a diversified portfolio of investments, to maintain sufficient cash reserves and to monitor both investment performance and the level of voluntary income received at each Board meeting.
## **Small companies provision statement**
This report has been prepared in accordance with the small companies regime under the Companies Act 2006.
The annual report was approved by the trustees of the charity on 31 January 2023 and signed on its behalf by:
L C Ellis Company Secretary
Page 4
## **Wythenshawe Hospital Transplant Fund**
## **Statement of Trustees' Responsibilities**
The trustees (who are also the directors of Wythenshawe Hospital Transplant Fund for the purposes of company law) are responsible for preparing the trustees' report and the financial statements in accordance with the United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice) and applicable law and regulations.
Company law requires the trustees to prepare financial statements for each financial year. Under company law the trustees must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the charitable company and of its incoming resources and application of resources, including its income and expenditure, for that period. In preparing these financial statements, the trustees are required to:
- select suitable accounting policies and apply them consistently;
- observe the methods and principles in the Charities SORP;
- make judgements and estimates that are reasonable and prudent;
- state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements; and
- prepare the financial statements on the going concern basis unless it is inappropriate to presume that the charitable company will continue in business.
The trustees are responsible for keeping adequate accounting records that are sufficient to show and explain the charitable company's transactions and disclose with reasonable accuracy at any time the financial position of the charitable company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the charitable company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
Page 5
Wythenshawe Hospital Transplant Fund
Independent Examiner's Report to the trustees of W)thenshawe Hospital Transplant Fund
I report to the charity trustees on my examination of the accounts of the charity for the year ended 31 March 2022
which are set oui on pages 7 to 19.
Respeetive responsibilitie5 of trnstees and examiner
A5 the charity'5 trustee5 of Wythellsliawe Hospital Trallsplant Fund (and dso its diTector5 for the purposes of
company lawl you are re%p)n%ible for the preparation of the accounts in accordance with the reqllirements of the
Conipanie5 Act 2006 ('the 2006 Act,).
Hdving Satisfied myself that the accounts of Wh¢ShaWe Hospital Trnnsplant Fund are not required to be audited
llndcr Part 16 of thc 2006 Act and arc cligiblc for indcpcndcnt cxamination, I rcport in rcspcct of my cxamination of
your ¢harity's atycounis as carried out under section 145 of Ihe Chariiies Act 2011 I'lhe 2011 Aci'l. In Carrying out
my exainination I have followed the Directioiis given by the Charity Coininis5ion under section 145(5)Ibl of the
Independent examiner's st8tement
I have completed my exainination. I confinn that no matters have coine to my attention in co[eCtiOn with the
examination giving m¢ Cause to believe..
accounting rccords wcrc not kcpt in rcsPCCt of WhCShaWC Hospital Transplant Fund as rcqllircd by scction
386 ot-lhe ?006 Act; or
2. thc aLcount8 do not aecord with tho8c rceord%' or
3. the accounts do not comply with the accounting requirements of section 396 of the 2006 Act other than any
requittn)ent thai the accourt¢s give a 'lrue and fair view, which Is not a matter considered as part of an
independent examination. or
4. the account5 Ive llot been prepared in accordance with the methods and principles of the Statement of
Recommended Practice for acenunting and reporting by charitie.% lapplicable to charities preparing their
accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ire[}d
IFRS 102)].
I have no ¢on¢erns and have come across no other matters in ¢onneciion with th¢ examination to whi¢h atteniion
should be dra1 in thi5 report iii order to enable a proper understandiiig of the account5 to be reached.
Maria Hallows BA (Econs). FCA, Dcha
Chartered Accountant
Beever and Stthers
One Express
l George Leigli Street
Manchester
M5 4DL
31 January 2023
Page 6
## **Wythenshawe Hospital Transplant Fund**
## **Statement of Financial Activities for the Year Ended 31 March 2022 (Including Income and Expenditure Account and Statement of Total Recognised Gains and Losses)**
|**Note**|**Unrestricted**
**funds**
**Restricted funds**
**Total**
**2022**|
|---|---|
||**£**
**£**
**£**|
|**Income and Endowments from:**||
|Donations and legacies
3|136,928
5,640
142,568|
|Other trading activities
4|60,598
-
60,598|
|Investment income
5|16,834
-
16,834|
|Total income|214,360
5,640
220,000|
|**Expenditure on:**||
|
Raising funds
6|(8,038)
-
(8,038)|
|Charitable activities
7|(75,622)
(904)
(76,526)|
|Total expenditure|(83,660)
(904)
(84,564)|
|Gains/losses on investment assets|20,059
-
20,059|
|Net income|150,759
4,736
155,495|
|Net movement in funds|150,759
4,736
155,495|
|**Reconciliation of funds**||
|Total funds brought forward|1,173,425
12,278
1,185,703|
|Total funds carried forward
17|1,324,184
17,014
1,341,198|
The notes on pages 10 to 19 form an integral part of these financial statements. Page 7
## **Wythenshawe Hospital Transplant Fund**
## **Statement of Financial Activities for the Year Ended 31 March 2022 (Including Income and Expenditure Account and Statement of Total Recognised Gains and Losses)**
|**Note**|**Unrestricted**
**funds**
**Restricted funds**
**Total**
**2021**|
|---|---|
||**£**
**£**
**£**|
|**Income and Endowments from:**||
|Donations and legacies
3|507,013
269
507,282|
|Other trading activities
4|43,148
-
43,148|
|Investment income
5|8,170
-
8,170|
|Total income|558,331
269
558,600|
|**Expenditure on:**||
|
Raising funds
6|(6,277)
-
(6,277)|
|Charitable activities
7|(659,023)
(27,398)
(686,421)|
|Total expenditure|(665,300)
(27,398)
(692,698)|
|Gains/losses on investment assets|49,413
-
49,413|
|Net expenditure|(57,556)
(27,129)
(84,685)|
|Net movement in funds|(57,556)
(27,129)
(84,685)|
|**Reconciliation of funds**||
|Total funds brought forward|1,230,981
39,407
1,270,388|
|Total funds carried forward
17|1,173,425
12,278
1,185,703|
All of the charity's activities derive from continuing operations during the above two periods. The funds breakdown for 2021 is shown in note 17.
The notes on pages 10 to 19 form an integral part of these financial statements. Page 8
Wythenshawe Hospital Transplant Fund
(Registration number: 2977135)
Balanee Sheet as at 31 March 2022
2022
2021
Note
Current llsset$
Stocks
Debiors
Investment5
Cagh at bank and in hand
200
200
13
240,324
551,809
650,917
424,195
435.818
424,419
15
1,443,250
1.284.632
Creditors: Amounts f#llirtg due within one ye#r
16
102,052
198,929
Nct asscts
,341.198
1,185,703
Funds of the eharity:
Restricted iThcome funds
Rcstrietcd funds
17,014
12.278
Unre$tricted income funds
UnrestriLttd funds
1,324,184
1,173,425
Total funds
17
1.341,198
1,185,703
FOT the financial year ending 31 March 2022 the chaTity was entitled to exemption from audit under sectloll 477 of
the Companies Act 2006 relating to small companies.
Directors, responsibilities..
The memberb have nol iequired the Lharily to obtain an audil of Lis acLounis for ihe year in queblion in
accordance '][h section 476; and
The director5 acknoivledge their responsibilities foT complying with the requirements of the Act with respect to
accounting records and the preparation of accounis.
Thcsc accoiints havc bccn prcparcd in accordancc with thc provisions applicablc to companics siibjcct to thc small
COMP¢1¢5 iegiine.
The
7 10 19 were approved by the trustees. and authorised for issue on 31 January
an
gnc
DKCO
Tiu&lL
The tJote5 on page5 10 to 19 fonn an integral part of tl)e5e financial statements.
Page 9
## **Wythenshawe Hospital Transplant Fund**
## **Notes to the Financial Statements for the Year Ended 31 March 2022**
## **1 Charity status**
The charity is a private company limited by guarantee, incorporated in England and Wales, and consequently does not have share capital. Each of the trustees is liable to contribute an amount not exceeding £1 towards the assets of the charity in the event of liquidation.
The address of its registered office is: The Transplant Fund Office Transplant Centre Wythenshawe Hospital Manchester M23 9LT
## **2 Accounting policies**
## **Summary of significant accounting policies and key accounting estimates**
The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.
## **Statement of compliance**
The financial statements have been prepared in accordance with Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2015) - (Charities SORP (FRS 102)), the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102). They also comply with the Companies Act 2006 and Charities Act 2011.
## **Basis of preparation**
Wythenshawe Hospital Transplant Fund meets the definition of a public benefit entity under FRS 102. Assets and liabilities are initially recognised at historical cost or transaction value unless otherwise stated in the relevant accounting policy notes.
The financial statements are prepared in sterling, which is the functional currency of the entity.
## **Going concern**
The Trustees have, at the time of approving the financial statements, a reasonable expectation that the charity has adequate resources to continue in operational existence for the foreseeable future. Thus, the trustees consider that there are no material uncertainties about the charity's ability to continue as a going concern nor any significant areas of uncertainty that affect the carrying value of assets held by the charity.
Page 10
## **Wythenshawe Hospital Transplant Fund**
## **Notes to the Financial Statements for the Year Ended 31 March 2022**
## **Critical accounting judgements and key sources of estimation uncertainty**
The preparation of the financial statements in conformity with FRS 102 requires the use of certain critical accounting estimates. It can also require the Trustees to exercise their judgement in the process of applying the charity's accounting policies. The charity is not considered to have any critical accounting estimates or judgements at this time.
## **Income and endowments**
All income is recognised once the charity has entitlement to the income, it is probable that the income will be received and the amount of the income receivable can be measured reliably.
## _**Donations and legacies**_
Donations are recognised when the charity has been notified in writing of both the amount and settlement date. In the event that a donation is subject to conditions that require a level of performance by the charity before the charity is entitled to the funds, the income is deferred and not recognised until either those conditions are fully met, or the fulfilment of those conditions is wholly within the control of the charity and it is probable that these conditions will be fulfilled in the reporting period.
Legacy gifts are recognised on a case by case basis following the grant of probate when the administrator/executor for the estate has communicated in writing both the amount and settlement date. In the event that the gift is in the form of an asset other than cash or a financial asset traded on a recognised stock exchange, recognition is subject to the value of the gift being reliably measurable with a degree of reasonable accuracy and the title to the asset having been transferred to the charity.
## _**Grants receivable**_
Grants are recognised when the charity has an entitlement to the funds and any conditions linked to the grants have been met. Where performance conditions are attached to the grant and are yet to be met, the income is recognised as a liability and included on the balance sheet as deferred income to be released.
## _**Investment income**_
Interest on deposits is recognised on an accruals basis.
## **Expenditure**
All expenditure is recognised once there is a legal or constructive obligation to that expenditure, it is probable settlement is required and the amount can be measured reliably. All costs are allocated to the applicable expenditure heading that aggregate similar costs to that category.
## _**Raising funds**_
These are costs incurred in attracting voluntary income, the management of investments and those incurred in trading activities that raise funds.
## _**Charitable activities**_
Charitable expenditure comprises those costs incurred by the charity in the delivery of its activities and services for its beneficiaries. It includes both costs that can be allocated directly to such activities and those costs of an indirect nature necessary to support them.
Page 11
## **Wythenshawe Hospital Transplant Fund**
## **Notes to the Financial Statements for the Year Ended 31 March 2022**
## **Taxation**
The charity is considered to pass the tests set out in Paragraph 1 Schedule 6 of the Finance Act 2010 and therefore it meets the definition of a charitable company for UK corporation tax purposes. Accordingly, the charity is potentially exempt from taxation in respect of income or capital gains received within categories covered by Chapter 3 Part 11 of the Corporation Tax Act 2010 or Section 256 of the Taxation of Chargeable Gains Act 1992, to the extent that such income or gains are applied exclusively to charitable purposes.
## **Current asset investments**
Investments, which include Open Ended Investment Companies authorised in the UK and corporate bond funds, are stated at the closing prices at the balance sheet date. The Statement of Financial Activities includes the net gains and losses arising on revaluation and disposals throughout the year.
## **Stock**
Stock is valued at the lower of cost and estimated selling price less costs to complete and sell, after due regard for obsolete and slow moving stocks. Cost is determined using the first-in, first-out (FIFO).
## **Trade debtors**
Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.
Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the charity will not be able to collect all amounts due according to the original terms of the receivables.
## **Cash and cash equivalents**
Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.
## **Fund structure**
Unrestricted income funds are general funds that are available for use at the trustees's discretion in furtherance of the objectives of the charity.
Restricted income funds are those donated for use in a particular area or for specific purposes, the use of which is restricted to that area or purpose.
## **Financial instruments**
## _**Classification**_
Financial assets and financial liabilities are recognised when the charity becomes a party to the contractual provisions of the instrument.
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the charity after deducting all of its liabilities.
Page 12
## **Wythenshawe Hospital Transplant Fund**
## **Notes to the Financial Statements for the Year Ended 31 March 2022**
## _**Recognition and measurement**_
All financial assets and liabilities are initially measured at transaction price (including transaction costs), except for those financial assets classified as at fair value through profit or loss, which are initially measured at fair value (which is normally the transaction price excluding transaction costs), unless the arrangement constitutes a financing transaction. If an arrangement constitutes a financing transaction, the financial asset or financial liability is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.
Financial assets and liabilities are only offset in the statement of financial position when, and only when there exists a legally enforceable right to set off the recognised amounts and the charity intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.
Financial assets are derecognised when and only when a) the contractual rights to the cash flows from the financial asset expire or are settled, b) the charity transfers to another party substantially all of the risks and rewards of ownership of the financial asset, or c) the charity, despite having retained some, but not all, significant risks and rewards of ownership, has transferred control of the asset to another party.
Financial liabilities are derecognised only when the obligation specified in the contract is discharged, cancelled or expires.
## **3 Income from donations and legacies**
||**Unrestricted**
**funds**
**Restricted**
**Total**|
|---|---|
||**General**
**funds**
**2022**|
||**£**
**£**
**£**|
|Donations and legacies;||
|Donations from individuals|45,264
640
45,904|
|Legacies|64,991
-
64,991|
|In memoriam|26,673
-
26,673|
|Grants, including capital grants;||
|Grants from companies|-
5,000
5,000|
||136,928
5,640
142,568|
||**Unrestricted**
**funds**
**Restricted**
**Total**|
||**General**
**funds**
**2021**|
||**£**
**£**
**£**|
|Donations and legacies;||
|Donations from individuals|30,344
269
30,613|
|Legacies|463,908
-
463,908|
|In memoriam|12,761
-
12,761|
||507,013
269
507,282|
Page 13
## **Wythenshawe Hospital Transplant Fund**
## **Notes to the Financial Statements for the Year Ended 31 March 2022**
- **4 Income from other trading activities**
|**4**
**Income from other trading activities**|||||
|---|---|---|---|---|
||**Unrestricted**||||
||**funds**|**Total**|**Total**||
||**General**|**2022**|**2021**||
||**£**|**£**|**£**||
|Trading income;|||||
|Income from sales of merchandise|3,792|3,792|4,425||
|Fundraisingevents|56,806|56,806|38,723||
||60,598|60,598|43,148||
## **5 Investment income**
|**5**
**Investment income**|||||
|---|---|---|---|---|
||**Unrestricted**||||
||**funds**|**Total**|**Total**||
||**General**|**2022**|**2021**||
||**£**|**£**|**£**||
|Interest receivable and similar income;|||||
|Interest receivable on bank deposits|59|59|769||
|Other income from current asset investments|-|-|413||
|Other investment income|16,775|16,775|6,988||
||16,834|16,834|8,170||
## **6 Expenditure on raising funds**
## **Costs of trading activities**
## **a)**
|**a)**
**Costs of trading activities**||
|---|---|
||**Unrestricted**
**funds**
**Total**
**Total**|
||**General**
**2022**
**2021**|
||**£**
**£**
**£**|
|Costs ofgoods sold|3,117
3,117
3,297|
||3,117
3,117
3,297|
Page 14
## **Wythenshawe Hospital Transplant Fund**
## **Notes to the Financial Statements for the Year Ended 31 March 2022**
## **Investment management costs**
## **b)**
|**b)**
**Investment management costs**||
|---|---|
||**Unrestricted**
**funds**
**Total**
**Total**|
||**General**
**2022**
**2021**|
||**£**
**£**
**£**|
|Finance charges;||
|Bank charges|140
140
-|
|Other investment management costs;||
|Amountspayable to investment managers|4,781
4,781
2,980|
||4,921
4,921
2,980|
|**7**
**Expenditure on charitable activities**||
||**Unrestricted**
**funds**
**Restricted**
**Total**|
||**General**
**funds**
**2022**|
||**£**
**£**
**£**|
|Medical supplies / equipment|39,225
-
39,225|
|Other charitable donations|2,074
-
2,074|
|Administration and other costs|10,958
904
11,862|
|Staff costs|23,365
-
23,365|
||75,622
904
76,526|
||**Unrestricted**
**funds**
**Restricted**
**Total**|
||**General**
**funds**
**2021**|
||**£**
**£**
**£**|
|Medical supplies / equipment|27,245
27,245
54,490|
|Refurbishment costs|480,260
-
480,260|
|Other charitable donations|117,164
153
117,317|
|Administration and other costs|8,610
-
8,610|
|Staff costs|25,744
-
25,744|
||659,023
27,398
686,421|
Page 15
## **Wythenshawe Hospital Transplant Fund**
## **Notes to the Financial Statements for the Year Ended 31 March 2022**
## **8 Net incoming/outgoing resources**
Net incoming/(outgoing) resources for the year include:
|Net incoming/(outgoing) resources for the year include:|||
|---|---|---|
||**2022**|**2021**|
||**£**|**£**|
|Finance charges payable|140|-|
|Independent Examiners Fee|2,340
2,340||
## **9 Trustees remuneration and expenses**
No trustees, nor any persons connected with them, have received any remuneration from the charity during the year.
No trustees have received any reimbursed expenses or any other benefits from the charity during the year.
## **10 Staff costs**
The aggregate payroll costs were as follows:
||**2022**
**2021**|
|---|---|
||**£**
**£**|
|**Staff costs during the year were:**||
|Wages and salaries|21,750
24,500|
|Pension costs|1,615
1,244|
||23,365
25,744|
The monthly average number of persons (including senior management team) employed by the charity during the year expressed as full time equivalents was as follows:
|year expressed as full time equivalents was as follows:||
|---|---|
||**2022**
**2021**|
||**No**
**No**|
|Administrative Staff|1
1|
No employee received emoluments of more than £60,000 during the year.
## **11 Taxation**
The charity is a registered charity and is therefore exempt from taxation.
Page 16
## **Wythenshawe Hospital Transplant Fund**
## **Notes to the Financial Statements for the Year Ended 31 March 2022**
|**12**
**Stock**||
|---|---|
||**2022**
**2021**|
||**£**
**£**|
|Stocks|200
200|
|**13**
**Debtors**||
||**2022**
**2021**|
||**£**
**£**|
|Legacies receivable|231,139
418,969|
|Prepayments|184
184|
|Other debtors|9,001
5,042|
||240,324
424,195|
|**14**
**Current asset investments**||
||**2022**
**2021**|
||**£**
**£**|
|Listed other shares|551,809
435,818|
|**15**
**Cash and cash equivalents**||
||**2022**
**2021**|
||**£**
**£**|
|Cash at bank|650,917
424,419|
|**16**
**Creditors: amounts falling due within one year**||
||**2022**
**2021**|
||**£**
**£**|
|Other taxation and social security|1,642
1,047|
|Accruals|100,410
97,882|
||102,052
98,929|
Page 17
## **Wythenshawe Hospital Transplant Fund**
## **Notes to the Financial Statements for the Year Ended 31 March 2022**
## **17 Funds**
|**17**
**Funds**||
|---|---|
||**Balance at 1**
**Incoming**
**Resources**
**Other**
**recognised**
**Balance at 31**|
||**April 2021**
**resources**
**expended**
**gains/(losses)**
**March 2022**|
||
**£**
**£**
**£**
**£**
**£**|
|**Unrestricted funds**||
|General|1,173,425
214,360
(83,660)
20,059
1,324,184|
|**Restricted funds**|12,278
5,640
(904)
-
17,014|
|**Total funds**|1,185,703
220,000
(84,564)
20,059
1,341,198|
||**Balance at 1**
**Incoming**
**Resources**
**Other**
**recognised**
**Balance at 31**|
||**April 2020**
**resources**
**expended**
**gains/(losses)**
**March 2021**|
||
**£**
**£**
**£**
**£**
**£**|
|**Unrestricted funds**||
|General|1,230,981
558,331
(665,300)
49,413
1,173,425|
|**Restricted funds**|39,407
269
(27,398)
-
12,278|
|**Total funds**|1,270,388
558,600
(692,698)
49,413
1,185,703|
The specific purposes for which the funds are to be applied are as follows:
The restricted income funds comprise amounts given by donors who indicate that their donations are to be spent on specific items to be used, or projects to be carried out, at Wythenshawe Hospital to further the objects of the charity. The balance at the year-end can be split between equipment for hearts £4,090 (2021: £4,445), expenditure for the bungalows £7,923 (2021: £7,833), educational grant £5,000 (2021: Nil).
Page 18
## **Wythenshawe Hospital Transplant Fund**
## **Notes to the Financial Statements for the Year Ended 31 March 2022**
|**18**
**Analysis of net assets between funds**||
|---|---|
||**Unrestricted**
**funds**
**Restricted**
**Total funds at 31**
**March**|
||**General**
**funds**
**2022**|
||**£**
**£**
**£**|
|Current assets|1,431,236
17,014
1,448,250|
|Current liabilities|(102,052)
-
(102,052)|
|Total net assets|1,329,184
17,014
1,346,198|
||**Unrestricted**
**funds**
**Restricted**
**Total funds at 31**
**March**|
||**General**
**funds**
**2021**|
||**£**
**£**
**£**|
|Current assets|1,272,354
12,278
1,284,632|
|Current liabilities|(98,929)
-
(98,929)|
|Total net assets|1,173,425
12,278
1,185,703|
Page 19